Cobimetinib
Cobimetinib ( trade name Cotellic ) is a MEK inhibitor developed by Exelixis and Genentech ( Roche ) . 
<triplet> Genentech <subj> Roche <obj> owned by <triplet> Roche <subj> Genentech <obj> subsidiary